Value Of BioPharma M&A Leaps in Q3
Roche Tops Big Pharma Alliances
Merck & Co's proposed acquisition of Acceleron and a couple of big purchases from Sanofi drove up the value of the sector's M&A activities, according to the latest report from Biomedtracker
